CIK 0001779372 · <br>Emerging growth company
HeartBeam, Inc.
Sign in to watch- Ticker
- BEAT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474881450
- Phone
- 408-899-4443
- Business address
- 2118 WALSH AVE., SUITE 210, SANTA CLARA, CA, 95050
Securities
- BEAT Common Stock Nasdaq
- BEATW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-14 | Persen Kenneth Harry Chief Technology Officer | Grant or award · Stock option (right to buy) | +169,000 | 169,000 | ||
| 2023-05-14 | Vajdic Branislav Chief Executive Officer | Grant or award · Stock option (right to buy) | +398,000 | 398,000 | ||
| 2023-03-21 | Persen Kenneth Harry Chief Technology Officer | Grant or award · Stock option (right to buy) | +60,000 | 60,000 | ||
| 2023-02-12 | Elfrink Willem Director | Conversion · Common Stock warrant (right to buy) | −43,636 | $0.00 | $131 | 0 |
| 2023-02-10 | Vajdic Branislav CHIEF EXECUTIVE OFFICER | Option exercise | +1,287 | 911,391 | ||
| 2023-02-10 | Vajdic Branislav CHIEF EXECUTIVE OFFICER | Option exercise · Common Stock Warrant (right to buy) | −5,090 | $3.68 | $19K | 728 |
| 2023-02-10 | Brounstein Richard Chief Financial Officer | Option exercise | +184 | 112,108 | ||
| 2023-02-10 | Brounstein Richard Chief Financial Officer | Option exercise · Common Stock Warrant (right to buy) | −727 | $3.68 | $3K | 728 |
| 2023-02-09 | Elfrink Willem Director | Returned to the company | −125,351 | 312,510 | ||
| 2023-02-09 | Elfrink Willem Director | Conversion | +3,640 | $2.75 | $10K | 316,150 |
| 2023-02-09 | Elfrink Willem Director | Conversion · Common Stock warrant (right to buy) | +3,640 | $2.75 | $10K | 0 |
| 2022-12-02 | Brounstein Richard Chief Financial Officer | Option exercise | +760 | $0.00 | $0 | 111,924 |
| 2022-12-02 | Brounstein Richard Chief Financial Officer | Option exercise · Stock option (right to buy) | −760 | 0 | ||
| 2022-11-02 | Brounstein Richard Chief Financial Officer | Option exercise | +759 | $0.00 | $0 | 111,164 |
| 2022-11-02 | Brounstein Richard Chief Financial Officer | Option exercise · Stock option (right to buy) | −759 | 760 | ||
| 2022-10-02 | Brounstein Richard Chief Financial Officer | Option exercise | +760 | $0.00 | $0 | 110,405 |
| 2022-10-02 | Brounstein Richard Chief Financial Officer | Option exercise · Stock option (right to buy) | −760 | 1,519 | ||
| 2022-09-16 | Persen Kenneth Harry Chief Technology Officer | Grant or award · Stock option (right to buy) | +80,000 | 80,000 | ||
| 2022-09-02 | Brounstein Richard Chief Financial Officer | Option exercise | +757 | $0.00 | $0 | 109,645 |
| 2022-09-02 | Brounstein Richard Chief Financial Officer | Option exercise · Stock option (right to buy) | −757 | 2,279 |
Page 5 of 8 · 149 trades